TCL Archive Pregnancy-Associated Breast Cancer More Likely Diagnosed At Advanced Stage February 27, 2009
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive In Brief: Junqueira Of Brazil Named Next UICC President, Murphy Gets Another Term as Secretary General September 5, 1980
TCL Archive ASCO Annual Meeting: NCI goals: Expand Clinical Trials, Build Informatics Network May 30, 1997
